Results 61 to 70 of about 1,793 (169)

Quality of Life in Alopecia Areata: A Sample of Tunisian Patients

Dermatology Research and Practice, 2013
Background. Alopecia areata (AA) has a significant impact on the quality of life and social interaction of those suffering from it. Our aim was to assess the impact of AA on the quality of life. Methods.
Jawaher Masmoudi, Rim Sellami, Uta Ouali, Leila Mnif, Ines Feki, Mariam Amouri, Hamida Turki, Abdellaziz Jaoua   +7 more
doaj   +1 more source

Do Alopecia Areata and Hair Colour Have a Shared Genetic Component?

Experimental Dermatology, Volume 35, Issue 6, June 2026.
The aim of our study was to determine whether hair colour and the risk of developing alopecia areata (AA) share a genetic basis. While we found no evidence for a broadly shared polygenic background, our analyses revealed suggestive evidence that genetically predicted blond hair is associated with a reduced risk of AA. ABSTRACT Alopecia areata (AA) is a
Leonie Rieger‐Molitor, Carlo Maj, Silke Redler, Yasmina Gossmann, Stephan Ripke, Lynn Pethukova, Angela M. Christiano, Markus M. Nöthen, F. Buket Basmanav, Regina C. Betz   +9 more
wiley   +1 more source

Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

The Journal of Dermatology, Volume 53, Issue 5, Page 746-757, May 2026.
ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source

Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older

Actas Dermo-Sifiliográficas
Alopecia areata (AA) is a dermatological disease of immune origin characterized by partial or total hair loss of the scalp (alopecia totalis) or the whole body (alopecia universalis).
S. Vañó-Galván, I. Figueras-Nart, C. Serrano, M.P. Fortes, V. Herrera-Lasso, R. Botella-Estrada   +5 more
doaj   +1 more source

Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis

Frontiers in Immunology
BackgroundAlopecia areata (AA) is a common autoimmune disorder causing patchy hair loss. Epidemiological observations and molecular studies collectively suggest an underrecognized interplay between AA and cardiovascular disease (CVD).
Jiawei Lu, Xuechen Cao, Yifei Feng, Yongkai Yu, Yan Lu   +4 more
doaj   +1 more source

“Hair is your crown and glory” – Black women’s experiences of living with alopecia and the role of social support

Health Psychology Report
Background Alopecia is an autoimmune condition that results in hair loss, mainly from the scalp. There are three specific types of auto-immune alopecia: alopecia areata (AA; small patches of hair loss), alopecia totalis (AT; total hair loss from the ...
Paige Clarke-Jeffers, Rebecca Keyte, Kathrina Connabeer   +2 more
doaj   +1 more source

Effect of Ayurveda modalities in the management of Alopecia Totalis

Journal of Ayurveda Case Reports
Alopecia is a significant growing concern among the generation of middle age group. Alopecia Totalis (AT) is defined as the loss of all skull and facial hair.
Shweta Mata, Shivshankar Rajput, Bharti Gupta   +2 more
doaj   +1 more source

Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis. [PDF]

Skin Res Technol, 2023
Koh YG, Han HS, Seok J, Choi SY, Li K, Kim BJ, Yoo KH.   +6 more
europepmc   +1 more source

Synchronous pancreas and gallbladder cancer with concomitant alopecia totalis. [PDF]

Turk J Surg, 2023
Kumar S, Chandra A.
europepmc   +1 more source

Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis. [PDF]

Int J Trichology, 2023
Varghese SA, Nair SS, George AE, Yadev I.   +3 more
europepmc   +1 more source